Exparel copromote?

Discussion in 'Stryker' started by Anonymous, Jun 14, 2013 at 12:40 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    331 study results come out next month. It's a nerve block trial but if it doesn't show superiority to generic bupivacaine, Pacira is screwed. If it is superior. J&J may buy it and then it will finally be commercialized properly. But if Pacira keeps it, Exparel will never be properly managed unless there's a thorough house cleaning at HQ.